rxstat › Classes › Intestinalantiinflammatory Agents
Intestinalantiinflammatory Agents: shortage status in Canada
2 of the 3 intestinalantiinflammatory agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Cromolyn (Opticrom) Partial shortage 2 of 5 reported products affected
Olsalazine (Dipentum) Partial shortage 1 of 1 reported products affected
Mesalazine (Salofalk) Shortage anticipated 0 of 11 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.